GAFFX
Price
$78.67
Change
+$0.76 (+0.98%)
Updated
Jun 6 closing price
Net Assets
304.87B
MFEKX
Price
$210.43
Change
+$2.12 (+1.02%)
Updated
Jun 6 closing price
Net Assets
45.69B
Interact to see
Advertisement

GAFFX vs MFEKX

Header iconGAFFX vs MFEKX Comparison
Open Charts GAFFX vs MFEKXBanner chart's image
American Funds Growth Fund of Amer F3
Price$78.67
Change+$0.76 (+0.98%)
VolumeN/A
Net Assets304.87B
MFS Growth R6
Price$210.43
Change+$2.12 (+1.02%)
VolumeN/A
Net Assets45.69B
GAFFX vs MFEKX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GAFFX vs. MFEKX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GAFFX is a StrongBuy and MFEKX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 305B vs. MFEKX (45.7B). GAFFX pays higher dividends than MFEKX: GAFFX (0.65) vs MFEKX (0.14). GAFFX was incepted earlier than MFEKX: GAFFX (8 years) vs MFEKX (14 years). MFEKX (0.50) is less costly to investors than GAFFX (0.30). MFEKX is a more actively managed with annual turnover of: 33.00 vs. GAFFX (25.00). MFEKX has a lower initial minimum investment than GAFFX: MFEKX (0) vs GAFFX (1000000). GAFFX annual gain was more profitable for investors over the last year : 9.74 vs. MFEKX (-0.95). MFEKX return over 5 years is better than : 51.49 vs. GAFFX (47.05).
GAFFXMFEKXGAFFX / MFEKX
Total Expense Ratio0.300.4961%
Annual Report Gross Expense Ratio0.300.5060%
Fund Existence8 years14 years-
Gain YTD5.6402.333242%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets305B45.7B667%
Annual Yield % from dividends0.650.14458%
Returns for 1 year9.74-0.95-1,021%
Returns for 3 years38.5637.75102%
Returns for 5 years47.0551.4991%
Returns for 10 yearsN/A181.79-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KALV14.360.56
+4.09%
KalVista Pharmaceuticals
BRC70.000.45
+0.65%
Brady Corp
PKX47.710.03
+0.06%
POSCO Holdings
SLS1.61-0.02
-1.23%
SELLAS Life Sciences Group
CNET1.26-0.06
-4.56%
ZW Data Action Technologies Inc